Affinity Prospective Diabetic Foot Trial Crossover Group
A Multi-center, Randomized Controlled Clinical Trial Evaluating the Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers: Crossover Group From Standard of Care
Sponsor: Organogenesis
Listed as NCT03205436, this NA trial focuses on Diabetic Foot Ulcer and remains completed. Sponsored by Organogenesis, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2018 — Mar 2020 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Aug 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Organogenesis
- SerenaGroup, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .